Login / Signup

Sodium-glucose co-transporter-2 inhibitor treatment in essential thrombocythemia: Impact on hemoglobin/hematocrit levels and outcomes among 11 consecutive patients.

Naseema GangatKaaren ReichardAyalew Tefferi
Published in: American journal of hematology (2023)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • red blood cell
  • replacement therapy